Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)

The summary for the Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
	CFDA Number:	93.279
	CFDA Description:	Drug Abuse and Addiction Research Programs
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PAR-11-060
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Dec 06, 2010
	Creation Date:	Dec 06, 2010
	Original Closing Date for Applications:	Sep 09, 2013
	Current Closing Date for Applications:	Sep 09, 2013
	Archive Date:	Oct 10, 2013
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	$350,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
Grant Description: Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages Resource-Related Research Project Grant (R24) applications from institutions that serve economically disadvantaged students andcommunities.Applications should propose to develop or strengthen the drug abuse research infrastructure at the institution and foster the research career development of a diverse cadre of faculty, students and staff who are currently underrepresented in drug abuse research. Mechanism of Support. This FOA will utilize the Resource-Related Research Projects (R24) grant mechanism. Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $350,000 in directcosts per year and time periods up to 5 years may be requested.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards supported will depend upon the mechanism number, quality, duration, and cost of the applications received. Budget and Project Period.Budgets for direct costs of up to $350,000 per year and project duration of up to 5 years may be requested.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-11-060.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1); • Pre-Application for the FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (X02); • Pre-Application for the 2012 NIDA Translational Avant-Garde Award for Medication Development for the...; • 2012 NIDA Translational Avant-Garde Award for Medication Development for the Treatment of Substance ...; • International Tobacco and Health Research and Capacity Building Program (R01); • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • DRUG ABUSE ASPECTS OF HIV/AIDS AND OTHER INFECTIONS; • EPIDEMIOLOGY OF DRUG ABUSE; • PRESCRIPTION DRUG ABUSE; • MDMA: RESEARCH AREAS NEEDING MORE EMPHASIS